These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 24318096

  • 1. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Iwagami S, Yoshida N, Oki E, Morita M, Nakao M, Baba H.
    Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
    [Abstract] [Full Text] [Related]

  • 2. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis.
    Baba Y, Nosho K, Shima K, Huttenhower C, Tanaka N, Hazra A, Giovannucci EL, Fuchs CS, Ogino S.
    Gastroenterology; 2010 Dec; 139(6):1855-64. PubMed ID: 20682317
    [Abstract] [Full Text] [Related]

  • 3. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
    Gao T, He B, Pan Y, Gu L, Chen L, Nie Z, Xu Y, Li R, Wang S.
    Clin Transl Oncol; 2014 Apr; 16(4):410-7. PubMed ID: 23943562
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
    Hidaka H, Higashimoto K, Aoki S, Mishima H, Hayashida C, Maeda T, Koga Y, Yatsuki H, Joh K, Noshiro H, Iwakiri R, Kawaguchi A, Yoshiura KI, Fujimoto K, Soejima H.
    Clin Epigenetics; 2018 Dec 04; 10(1):150. PubMed ID: 30509319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer.
    Ito Y, Koessler T, Ibrahim AE, Rai S, Vowler SL, Abu-Amero S, Silva AL, Maia AT, Huddleston JE, Uribe-Lewis S, Woodfine K, Jagodic M, Nativio R, Dunning A, Moore G, Klenova E, Bingham S, Pharoah PD, Brenton JD, Beck S, Sandhu MS, Murrell A.
    Hum Mol Genet; 2008 Sep 01; 17(17):2633-43. PubMed ID: 18541649
    [Abstract] [Full Text] [Related]

  • 8. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
    Schagdarsurengin U, Lammert A, Schunk N, Sheridan D, Gattenloehner S, Steger K, Wagenlehner F, Dansranjavin T.
    Cell Commun Signal; 2017 Oct 10; 15(1):40. PubMed ID: 29017567
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Loss of imprinting of IGF2 in fibroadenomas and phyllodes tumors of the breast.
    Mishima C, Kagara N, Tanei T, Naoi Y, Shimoda M, Shimomura A, Shimazu K, Kim SJ, Noguchi S.
    Oncol Rep; 2016 Mar 10; 35(3):1511-8. PubMed ID: 26676988
    [Abstract] [Full Text] [Related]

  • 11. DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer.
    Watanabe H, Higashimoto K, Miyake N, Morita S, Horii T, Kimura M, Suzuki T, Maeda T, Hidaka H, Aoki S, Yatsuki H, Okamoto N, Uemura T, Hatada I, Matsumoto N, Soejima H.
    FASEB J; 2020 Jan 10; 34(1):960-973. PubMed ID: 31914674
    [Abstract] [Full Text] [Related]

  • 12. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
    Zhang FR, He XB, Yang YH, Xie W.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb 10; 20(1):31-4. PubMed ID: 12579496
    [Abstract] [Full Text] [Related]

  • 13. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
    Zuo QS, Yan R, Feng DX, Zhao R, Chen C, Jiang YM, Cruz-Correa M, Casson AG, Kang XD, Han F, Chen T.
    Mol Carcinog; 2011 May 10; 50(5):390-6. PubMed ID: 21268128
    [Abstract] [Full Text] [Related]

  • 14. Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.
    Zhao R, DeCoteau JF, Geyer CR, Gao M, Cui H, Casson AG.
    Carcinogenesis; 2009 Dec 10; 30(12):2117-22. PubMed ID: 19843644
    [Abstract] [Full Text] [Related]

  • 15. Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region.
    Nishihara R, Wang M, Qian ZR, Baba Y, Yamauchi M, Mima K, Sukawa Y, Kim SA, Inamura K, Zhang X, Wu K, Giovannucci EL, Chan AT, Fuchs CS, Ogino S, Schernhammer ES.
    Am J Clin Nutr; 2014 Dec 10; 100(6):1479-88. PubMed ID: 25411283
    [Abstract] [Full Text] [Related]

  • 16. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
    Kawano H, Saeki H, Kitao H, Tsuda Y, Otsu H, Ando K, Ito S, Egashira A, Oki E, Morita M, Oda Y, Maehara Y.
    Ann Surg Oncol; 2014 Dec 10; 21 Suppl 4():S696-702. PubMed ID: 24898425
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.
    Bhusari S, Yang B, Kueck J, Huang W, Jarrard DF.
    Prostate; 2011 Nov 10; 71(15):1621-30. PubMed ID: 21432864
    [Abstract] [Full Text] [Related]

  • 18. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression.
    Dejeux E, Olaso R, Dousset B, Audebourg A, Gut IG, Terris B, Tost J.
    Endocr Relat Cancer; 2009 Sep 10; 16(3):939-52. PubMed ID: 19502451
    [Abstract] [Full Text] [Related]

  • 19. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus.
    Waterland RA, Lin JR, Smith CA, Jirtle RL.
    Hum Mol Genet; 2006 Mar 01; 15(5):705-16. PubMed ID: 16421170
    [Abstract] [Full Text] [Related]

  • 20. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
    Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, Nichols TD, Marks JR, Berchuck A.
    Mol Cancer Res; 2006 Apr 01; 4(4):283-92. PubMed ID: 16603642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.